Document is current
Any future updates will be listed below
-
Authors
Yang, Jingyun
He, Xuemei
Shi, Huashan https://orcid.org/0000-0002-9958-9892
He, Cai
Lei, Hong
He, Heng
Yang, Li
Wang, Wei https://orcid.org/0000-0001-7788-1895
Shen, Guobo https://orcid.org/0000-0002-8917-196X
Yang, Jinliang
Zhao, Zhiwei
Song, Xiangrong https://orcid.org/0000-0002-2853-2696
Wang, Zhenling
Lu, Guangwen https://orcid.org/0000-0001-7568-592X
Li, Jiong https://orcid.org/0000-0002-3742-630X
Wei, Yuquan
-
Funding
Funding for this research was provided by:
China Postdoctoral Science Foundation (2023T160458)
- License Information
-
More Information
Article History
Received: 21 November 2024
Revised: 5 January 2025
Accepted: 13 January 2025
First Online: 27 January 2025
Competing interests
: This work was supported by the WestVac Biopharma Co. Ltd. Jingyun Yang, Jiong Li, L.Y., Z.W., W.W., G.S., Jinliang Yang, Z.Z., Yuquan Wei, G.L. and X.W. are also working at the WestVac Biopharma Co. Ltd. Yu-Quan Wei is one of the Editors-in-Chief of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling. The remaining authors declare no competing interests.
